Morning Overview on MSN
DNA-based system targets cancer cells, a step toward smarter drugs
Researchers have built DNA-based nanodevices that can identify cancer cells, latch onto them, and deliver drugs or ...
Add Yahoo as a preferred source to see more of our stories on Google. CHICAGO — A big breakthrough in cancer research and it’s all due to a tiny structure. The science was developed in Chicago. They ...
Fox Chase researchers use 3D genomic testing to improve lymphoma and sarcoma diagnosis and treatment by revealing tumor cell ...
VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, is the first to demonstrate the isolation and analysis of >99% pure circulating tumor-derived DNA (ctDNA).
Unlock the latest liquid biopsy market data. Explore growth drivers, precision oncology shifts, and the tech fueling ...
CHICAGO — A big breakthrough in cancer research and it’s all due to a tiny structure. The science was developed in Chicago. They took an old drug and made it better. The restructured drug appears to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results